School of Nursing and Midwifery, Institutes of Health Sciences, Wollega University, Nekemte, Ethiopia.
Department of Public Health, Institutes of Health Sciences, Wollega University, Nekemte, Ethiopia.
PLoS One. 2020 Nov 11;15(11):e0241768. doi: 10.1371/journal.pone.0241768. eCollection 2020.
First-line antiretroviral treatment failure has become a public health concern in high, low and middle-income countries with high mortality and morbidity In Ethiopia, around 710,000 peoples were living with HIV and 420,000 of them were receiving ART in 2017. Little is known about the magnitude of first-line ART treatment failure and its associated factors in Ethiopia, particularly in the study area. Therefore, this study was aimed to find the magnitude of first-line ART treatment failure and its associated factors among adult patients attending ART clinic at Southwest shoa zone public hospitals.
Institutions based cross-sectional study was employed from February 1 to April 2, 2019. An interviewer administered questionnaire was used to collect data from 350 adult patients on ART using a systematic random sampling technique. The collected data were coded and entered into Epidata version 3 and exported to STATA SE version 14 for analysis. Bivariable and multivariable logistic regression was done to identify factors associated with first-line ART treatment failure. At 95% confidence level strength of association was measured using Odds ratio. Variables with a p-value of ≤ 0.25 in the bivariable analysis were considered as a candidate variable for multivariable analysis. To get the final variables step-wise backward selection procedure was used and those in the final model were selected at a p-value <0.05. Finally, texts, simple frequency tables, and figures were used to present the findings.
In this study the magnitude of first-line ART treatment failure was 33.42%. Absence of baseline opportunistic infection AOR = 0.362 (95%CI0.178, 0.735), Staying on first-line ART for <5 years AOR = 0.47 (95%CI 0.252, 0.878), Nevirapine containing ART regimen AOR = 3.07 (95%CI 1.677, 5.63), Baseline CD4 count ≥100 cells/mm3 AOR = 0.299 (95%CI 0.152 0.591), absence of opportunistic infections after ART initiation AOR = 0.257 (95%CI 0.142, .467), time taking greater than an one-hour to reach health facility AOR 1.85 (95%CI 1.022 3.367) were significantly associated with first-line ART treatment failure.
The magnitude of first-line ART treatment failure was high in the study area. Base-line opportunistic infection, duration on first-line ART, NVP based ART, Baseline CD4 count level, OI after ART initiation, and time it takes to reach health facility were independent determinants of first-line ART treatment failure.
一线抗逆转录病毒治疗失败已成为高、中、低收入国家的一个公共卫生问题,这些国家的死亡率和发病率都很高。在埃塞俄比亚,大约有 71 万人感染了艾滋病毒,2017 年有 42 万人正在接受抗逆转录病毒治疗。在埃塞俄比亚,特别是在研究地区,人们对一线抗逆转录病毒治疗失败的程度及其相关因素知之甚少。因此,本研究旨在探讨在西南绍阿地区公立医院接受抗逆转录病毒治疗的成年患者中,一线抗逆转录病毒治疗失败的程度及其相关因素。
这是一项 2019 年 2 月 1 日至 4 月 2 日在机构基础上进行的横断面研究。采用问卷调查的方式,从 350 名接受抗逆转录病毒治疗的成年患者中收集数据,采用系统随机抽样技术。将收集到的数据进行编码,输入到 EpiData 版本 3 中,并导出到 STATA SE 版本 14 进行分析。采用单变量和多变量逻辑回归分析确定与一线抗逆转录病毒治疗失败相关的因素。在 95%置信水平下,使用优势比来衡量关联的强度。单变量分析中 p 值≤0.25 的变量被认为是多变量分析的候选变量。采用逐步向后选择程序获得最终变量,选择 p 值<0.05 的变量进入最终模型。最后,使用文本、简单频率表和图形来呈现研究结果。
本研究中,一线抗逆转录病毒治疗失败的比例为 33.42%。基线时无机会性感染(AOR=0.362,95%CI0.178,0.735)、一线抗逆转录病毒治疗时间<5 年(AOR=0.47,95%CI 0.252,0.878)、含奈韦拉平的抗逆转录病毒治疗方案(AOR=3.07,95%CI 1.677,5.63)、基线 CD4 计数≥100 个细胞/mm3(AOR=0.299,95%CI 0.152,0.591)、抗逆转录病毒治疗后无机会性感染(AOR=0.257,95%CI 0.142,0.467)、到达医疗机构的时间超过 1 小时(AOR 1.85,95%CI 1.022,3.367)与一线抗逆转录病毒治疗失败显著相关。
该研究地区一线抗逆转录病毒治疗失败的比例较高。基线时的机会性感染、一线抗逆转录病毒治疗的时间、基于 NVP 的抗逆转录病毒治疗、基线 CD4 计数水平、抗逆转录病毒治疗后出现机会性感染以及到达医疗机构所需的时间是一线抗逆转录病毒治疗失败的独立决定因素。